A laboratory worker’s death from severe pneumonia in Siberia has prompted medical monitoring of nearly 200 people after reports that she may have been exposed to live bacteria during an incident at a research institute.
The worker, identified in reports as 28-year-old Daria Shipilova, was employed at the Irkutsk Anti-Plague Research Institute.
Reports said she accidentally broke a test tube containing biological material while working at the facility on September 25 and later informed medical staff about the incident.
Shipilova was admitted to a hospital in Shelekhov four days later with severe pneumonia. Her condition deteriorated rapidly, requiring mechanical ventilation, and she died several days afterward.
The reported laboratory incident has raised concerns about possible exposure to Yersinia pestis, the bacterium responsible for plague. However, Russian health authorities have not confirmed the possible reasons of her death.
Russia's public-health watchdog, Rospotrebnadzor, has described the illness as pneumonia of unknown origin and said the sanitary and epidemiological situation in the Irkutsk region remains stable.
The concern surrounding the case is linked to the possibility of pneumonic plague, one of the three major clinical forms of plague.
Plague is caused by Yersinia pestis, which naturally circulates among certain small mammals and their fleas.
Humans can become infected through infected flea bites, contact with infected animals or their tissues, and, in pneumonic cases, exposure to infectious respiratory particles.
Bubonic plague is the most commonly recognised form. It usually causes fever, weakness and painful swelling of lymph nodes, known as buboes.
Septicemic plague occurs when the bacteria enter and multiply in the bloodstream. It can cause severe systemic illness and may develop from another form of plague or appear as the initial infection.
Pneumonic plague affects the lungs and is particularly significant from a public-health perspective because it can spread between people through respiratory droplets or particles. Such transmission generally involves close and sustained contact.
According to the World Health Organization, Pneumonic plague can develop after a relatively short incubation period and symptoms may appear within 24 hours of infection.
Symptoms include fever, headache, weakness, cough, chest pain and difficulty breathing. In some cases, patients may also produce watery or blood-stained mucus.
The disease can become life-threatening quickly if untreated.
However, plague is treatable with antibiotics when detected and treated promptly.
Health authorities recommend starting appropriate antimicrobial treatment when plague is suspected rather than waiting for laboratory confirmation. Diagnosis can involve testing samples such as blood, sputum or material from swollen lymph nodes.
In the Siberian case, the distinction is important because severe pneumonia by itself does not establish that the patient had pneumonic plague.
Nearly 200 people have reportedly been placed under observation in connection with the Siberian case.
Reports said those being monitored had not shown signs of illness and that tests had so far been negative. Some medical facilities have also introduced precautionary restrictions.
The monitoring therefore reflects a precautionary response to a potentially serious exposure rather than confirmation of a plague outbreak.
Although plague is strongly associated with historical pandemics, Yersinia pestis continues to circulate in parts of the world.
The World Health Organization says human plague remains endemic in some regions, with the Democratic Republic of the Congo and Madagascar among the countries that have reported significant numbers of cases in recent years.
In Siberia, however, the available information does not establish that plague caused Shipilova's death or that an outbreak has occurred.
For now, health authorities are monitoring those potentially exposed while investigations continue. The key question remains whether subsequent testing will establish a connection between the reported laboratory incident and the woman's illness.
